Opportunities and risks of diagnostic lab-on-a-chip systems in healthcare from a health system stakeholder's perspective

Personalized Medicine
Wolfgang HoffmannSilke Schmidt

Abstract

The aim of personalized medicine is to respond to the needs of individuals with appropriate treatment. Lab-on-a-chip systems (LOCs) can help to individualize therapeutic algorithms at the point of care. Herein, we discuss the perspectives, demands and concerns associated with LOCs. Interviews with 30 experts in the field of personalized medicine were conducted, addressing the requirements, potentials and risks of LOCs. The interviews were transcribed and evaluated by means of qualitative content analysis. The majority of experts emphasize a considerable potential for the lab-on-a-chip industry with the largest potential in the context of point-of-care diagnostics. The direct-to-costumer use is regarded as risky, in particular with respect to the reliability of the results. In addition to a major potential of the implementation of LOCs, their impact on delivery of healthcare have to be considered, and early communication between physicians and LOC developers and manufacturers have to be ensured.

References

Apr 12, 2001·Journal of the American Pharmaceutical Association : APhA·F R Ernst, A J Grizzle
Jan 17, 2004·Health Policy·Erika SchulzHans-Helmut König
Jul 28, 2006·Nature·Paul YagerBernhard H Weigl
Apr 17, 2008·Angewandte Chemie·Juergen PipperTseng-Ming Hsieh
Feb 22, 2012·Lab on a Chip·Curtis D ChinSamuel K Sia
Aug 16, 2012·Journal of Laboratory Automation·Kin Fong Lei
Oct 9, 2012·Nature Nanotechnology·Pedro M ValenciaRobert Langer
Jun 4, 2013·Advanced Drug Delivery Reviews·Katla Sai KrishnaChalla S S R Kumar
Jan 1, 2012·Personalized Medicine·Kathleen Kraft, Wolfgang Hoffmann
Sep 1, 2011·Personalized Medicine·Kathleen KraftWolfgang Hoffmann

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
chip

Software Mentioned

MAXQDA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.